Proem Acquisition Corp I (NASDAQ:PAAC – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 25,134 shares, a decrease of 44.4% from the September 30th total of 45,191 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 44,123 shares, the short-interest ratio is presently 0.6 days.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded Proem Acquisition Corp I from a “sell (e)” rating to a “sell (e+)” rating in a research report on Friday, October 9th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.
Get Our Latest Stock Report on PAAC
Proem Acquisition Corp I Stock Performance
Shares of Proem Acquisition Corp I stock remained flat at $10.01 during trading on Friday. The stock had a trading volume of 32,352 shares, compared to its average volume of 19,108. Proem Acquisition Corp I has a 52-week low of $9.83 and a 52-week high of $10.15. The firm has a 50-day simple moving average of $10.05.
Institutional Trading of Proem Acquisition Corp I
A hedge fund recently raised its position in Proem Acquisition Corp I stock. Readystate Asset Management LP grew its holdings in Proem Acquisition Corp I (NASDAQ:PAAC – Free Report) by 2.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 139,414 shares of the company’s stock after buying an additional 2,888 shares during the period. Readystate Asset Management LP owned approximately 0.79% of Proem Acquisition Corp I worth $1,451,000 as of its most recent filing with the Securities & Exchange Commission.
About Proem Acquisition Corp I
Further Reading
- Five stocks we like better than Proem Acquisition Corp I
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Proem Acquisition Corp I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proem Acquisition Corp I and related companies with MarketBeat.com's FREE daily email newsletter.
